Thursday, September 27, 2012 12:21:31 PM
2. The Defendants' scheme had two facets which they executed simultaneously. One facet involved Bryant's and Kelly's dissemination of financial reports and press releases falsely reflecting that EIGH had millions of dollars in capital and revenues. The other facet involved Duncan supplying OTC Markets Group, Inc. ("OTC Markets") and EIGH's transfer agent with false legal opinions. The opinions that Duncan provided OTC Markets assured that EIGH's common stock was quoted in a central market widely available to investors. The opinions that he provided the transfer agent enabled Bryant to acquire stock certificates without restrictive legends for EIGH's restricted securities, thereby allowing Bryant to sell 56.8 million EIGH shares into the market that he could not have otherwise sold.
3.The Defendants' combined efforts increased the volume of trading in EIGH by 93% between November 2009 and October 2010, and the company's stock price from less than $0.01 to $0.42 per share. Further, Bryant and Kelly earned substantial profits through the scheme. Bryant paid Duncan more than $15,000 from his trading profits for Duncan's services. Bryant also gave one million shares ofEIGH's common stock to Duncan. The Commission issued an order on November 4, 2010, suspending trading in EIGH's securities.
4. By engaging in the scheme to increase the volume of trading in EIGH's securities and the company' stock price, Defendants violated the antifraud provisions ofthe federal securities laws. Bryant and Duncan also violated the securities registration provisions of the federal securities laws by participating in the sale of EIGH's restricted securities.
SEC Complaint
http://www.sec.gov/litigation/complaints/2012/comp22495.pdf
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM